Japanese Early-stage Clinical Trial of Ultra-high Dose Methylcobalamin for Amyotrophic Lateral Sclerosis: a Pivotal Phase 3 Randomized Controlled Study
Latest Information Update: 01 Apr 2025
At a glance
- Drugs Mecobalamin (Primary)
- Indications Amyotrophic lateral sclerosis
- Focus Registrational; Therapeutic Use
- Acronyms JETALS
- 26 Mar 2025 Status changed from active, no longer recruiting to completed.
- 11 Feb 2025 Arms increased from 2 to 4. OLE Phase added newly.
- 11 Feb 2025 Planned End Date changed from 31 Mar 2020 to 15 Apr 2025.